GLP-1 Atlas — Evidence-led GLP-1 clinical reference for healthcare professionals https://glp1ra.co.uk/ Independent, evidence-led GLP-1 receptor agonist clinical reference for healthcare professionals: mechanisms, landmark trials, prescribing guidance, patient selection, safety and regulatory alerts. en-gb Tue, 20 Oct 2026 00:00:00 GMT Mechanisms — GLP-1 Atlas https://glp1ra.co.uk/mechanism/ https://glp1ra.co.uk/mechanism/ Thu, 21 May 2026 00:00:00 GMT Explore GLP-1 receptor biology, incretin physiology, signalling pathways and organ-level mechanisms with annotated clinical figures. Drug classes — GLP-1 Atlas https://glp1ra.co.uk/drug-classes/ https://glp1ra.co.uk/drug-classes/ Thu, 21 May 2026 00:00:00 GMT Compare GLP-1 receptor agonists, dual agonists, pharmacokinetics, dosing characteristics and the next-generation clinical pipeline. Evidence — GLP-1 Atlas https://glp1ra.co.uk/clinical-evidence/ https://glp1ra.co.uk/clinical-evidence/ Thu, 21 May 2026 00:00:00 GMT Review landmark GLP-1 trials across diabetes, obesity, cardiovascular, renal and metabolic outcomes in a structured evidence atlas. Guidelines — GLP-1 Atlas https://glp1ra.co.uk/guidelines/ https://glp1ra.co.uk/guidelines/ Thu, 21 May 2026 00:00:00 GMT Navigate NICE-aligned GLP-1 prescribing guidance, clinical algorithms, eligibility criteria and practical treatment recommendations. Selection — GLP-1 Atlas https://glp1ra.co.uk/patient-selection/ https://glp1ra.co.uk/patient-selection/ Thu, 21 May 2026 00:00:00 GMT Use practical frameworks to select appropriate GLP-1 therapy by comorbidity, treatment goal, contraindication and shared decision-making. Safety — GLP-1 Atlas https://glp1ra.co.uk/side-effects/ https://glp1ra.co.uk/side-effects/ Thu, 21 May 2026 00:00:00 GMT Recognise, prevent and manage GLP-1 adverse effects with practical safety guidance, red flags and monitoring frameworks. Scenarios — GLP-1 Atlas https://glp1ra.co.uk/special-scenarios/ https://glp1ra.co.uk/special-scenarios/ Thu, 21 May 2026 00:00:00 GMT Clinical guidance for GLP-1 therapy in renal, hepatic, perioperative, reproductive, older and other higher-risk populations. Alerts — GLP-1 Atlas https://glp1ra.co.uk/regulatory-alerts/ https://glp1ra.co.uk/regulatory-alerts/ Thu, 21 May 2026 00:00:00 GMT Track important GLP-1 safety communications and regulatory updates from MHRA, EMA, FDA and NICE in one clinical reference.